where do compounding pharmacies get semaglutide FDA Warns on Certain Forms of Compounded How the FDA's Semaglutide Ruling
Description
EMPA-KIDNEY Trial (n=6,609) This chronic kidney disease trial showed Jardiance reduced kidney disease progression and cardiovascular death risk, with benefits persisting up to one year after treatment discontinuation

In contrast, more than 80% of those starting SGLT2 or insulin added another medication

doi: 10.1023/A:1006133620914

But that interest should not be confused with proven, standard-of-care use in humans

2016, Harlan-Teklad)

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes Phase 2 trial
